• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS, INC. PULSE GEN MODEL 103; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS, INC. PULSE GEN MODEL 103; GENERATOR Back to Search Results
Model Number 304-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dysphagia/ Odynophagia (1815); Pain (1994); Tissue Breakdown (2681); No Information (3190)
Event Date 07/25/2011
Event Type  Injury  
Event Description
It was reported that the patient was referred for a vns removal surgery.The surgeon indicated that the patient¿s caregiver believed that the vns only made things worse for the patient.The exact adverse event was not specified at the time of the report.Follow up with the office of the surgeon showed that the patient had her vns generator and leads removed.The devices were reportedly discarded following explant.No additional pertinent information has been received to date.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Communication with the office of the treating neurologist showed that the patient was experiencing vns site discomfort.It was assessed to be due to the device presence and was likely occurring since device implant.One of the lead tie-downs appeared to be protruding, and it was assessed that it was due to the patient being small.The explant was believed to be just for comfort and was not to preclude a serious injury.Further information directly from the treating physician showed that the patient¿s lead was eroding through the skin, which was causing discomfort.He was not aware if the skin was broken at the lead site, as the patient¿s site was always either covered up with clothing or medical dressing.Communications with the office of the surgeon showed that all they knew regarding the patient¿s vns was that they were told the patient's mother thought the lead was affecting the patient¿s swallowing, likely from device stimulation.Notes on what was observed at the lead site were not taken, and it could not be recalled what was observed regarding the reported skin erosion.No additional pertinent information has been received to date.
 
Manufacturer Narrative
The suspect device was inadvertently provided as the generator, and the model#, serial#, lot#, expiration date were inadvertently incorrect as a result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 103
Type of Device
GENERATOR
Manufacturer (Section D)
CYBERONICS, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
CYBERONICS, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key6434719
MDR Text Key70860382
Report Number1644487-2017-03467
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/30/2015
Device Model Number304-20
Device Lot Number201780
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Date Manufacturer Received04/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/17/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 YR
-
-